Afficher la notice abrégée

dc.contributor.editorZerr, Inga
dc.date.accessioned2021-04-20T15:51:11Z
dc.date.available2021-04-20T15:51:11Z
dc.date.issued2015
dc.identifierONIX_20210420_9789535121374_2066
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/66707
dc.description.abstractThere is a wide scope of clinical phenomenology in Alzheimers disease, regarding the age of onset, presenting features, rate of progression and appearance of other clinical manifestation. Although clinical appearance and neuropathological hallmarks have been defining AD since its first description, major factors which trigger pathology are still unknown. The role of comorbidity is discussed controversially. Important environmental risk factors in AD development are continuous stress, low education and cardiovascular risk factors such as alcohol intake, smoking, hypertension. The role of lipids and cholesterol has been recognized, but the relevant pathogenetic steps are still to be identified. There is an urgent need to understand molecular disease pathogenesis in order to develop early therapeutic targets for the disease.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKJ Neurology and clinical neurophysiologyen_US
dc.subject.otherNeurology & clinical neurophysiology
dc.titleAlzheimer's Disease
dc.title.alternativeChallenges for the Future
dc.typebook
oapen.identifier.doi10.5772/58663
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9789535121374
oapen.relation.isbn9789535172420
oapen.imprintIntechOpen
oapen.pages372


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/3.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/3.0/